Executive Team andBoard of Directors firstname.lastname@example.org
- Stephen Punzak, M.D. – Founder and Chief Executive Officer
- John Meadows – Chief Growth Officer
- Eric Akstin – Chief Technology Officer
- Ellyn Nardone – Vice President, Quality Management
- Dan Short – Vice President, Corporate Accounts
Board of Directors
Stephen Punzak, M.D.
Stephen Punzak, M.D., is the founder and CEO of One Medical Passport, Inc., a company that is revolutionizing the pre-op screening process for surgical patients. The One Medical Passport system, first envisioned by Dr. Punzak over a decade ago, has been adopted by hundreds of medical facilities nationwide. This system has streamlined the pre-op and day-of-surgery workflow and resulted in marked improvements in patient safety and convenience.
In addition to being the hands-on CEO of a rapidly growing company, Dr. Punzak still practices clinical anesthesia, noting, “this is where many of the company’s best ideas for product development have come from.” Dr. Punzak’s more than 20-year career as an anesthesiologist has included a range of challenges, from performing complex open heart and liver transplant surgeries at the Deaconess Hospital in Boston, to fast-paced ambulatory surgeries, pain management and obstetrical anesthesia. He attained board certification in both anesthesiology and pain management. During his work on the front lines of an anesthesia practice, Dr. Punzak experienced first-hand the inefficiencies and shortcomings of the traditional pre-op process. This experience inspired him to found MWT to make the process much more efficient.
Dr. Punzak graduated from the Boston College School of Management in 1983 with a major in finance and a minor in pre-med studies. He was the first graduate of Boston College to simultaneously receive the Scholar of the College Award in Biology and to be chosen as the commencement speaker for the School of Management. Dr. Punzak attended the University of Connecticut School of Medicine and did his residency in anesthesiology at the Brigham and Women’s Hospital in Boston.
Christoph Hoffmann practiced corporate law at Bingham, Dana & Gould before moving into executive positions at Textron Inc., Pneumo Corporation and Raytheon Company. His corporate career included responsibilities in the legal, M&A, administrative and operational areas. Mr. Hoffmann is currently a Director of Red Lodge Ales Brewing Company and a limited partner of Carlisle Enterprises, LLC, a private equity firm. He has been active in various governance positions at Beth Israel Deaconess Hospital-Needham, including chairing its Board of Trustees for four years. Mr. Hoffmann is a member of the Corporate Directors Group.
Stephen W. Earnhart
Stephen Earnhart has a broad clinical and educational background in healthcare spanning over 30 years. He is the Founder and Chief Executive Officer of Earnhart & Associates, an international healthcare-consulting firm that caters to large healthcare systems, private sector investors, publicly-traded and privately-held organizations. Earnhart & Associates focuses on issues related to acquisition, development, and efficient and effective management of health care services and facilities. Mr. Earnhart has extensive experience in the creation of private sector health services in countries with socialized health systems. He is the author of over 200 publications on healthcare organization, management and revenue enhancement.
John R. Burch
Mr. Burch is a Partner of FCA Venture Partners and has over 26 years of business experience and 18 years of angel and venture capital investing experience. Mr. Burch is focused on deal generation, due diligence, investment structuring and portfolio management. (full bio)
Mr. Bouldin leads FCA’s deal sourcing, analysis, and due diligence process, reviewing over 400 investment opportunities annually. He adds value to portfolio companies through operational advice, customer introductions, recruiting candidates, and assistance with financial initiatives. (full bio)
Matthew A. King
Mr. King is the Managing Partner of FCA Venture Partners and has over 30 years of business experience, the last 13 of which have been focused exclusively in the venture capital industry. Mr. King oversees all of the FCA Fund’s including: identifying potential investments, portfolio management, investment structuring, syndicate leadership, due diligence, and dispositions for FCA V. (full bio)